Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients

Bone Marrow Transplant. 2022 Jan;57(1):128-130. doi: 10.1038/s41409-021-01486-5. Epub 2021 Oct 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetates
  • Antiviral Agents
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Quinazolines
  • Sirolimus / therapeutic use
  • Transplant Recipients*

Substances

  • Acetates
  • Antiviral Agents
  • Quinazolines
  • letermovir
  • Sirolimus